DeepMed Research

Ethanol

Generic Name: Ethanol

Brand Names: Dalmacol, Gattex, Healing Waters Aloe Cucumber Hand Sanitizer, Healing Waters Cotton Blossom Hand Sanitizer, Healing Waters Lemon Verbena Hand Sanitizer, Healing Waters Peach Nectarine Hand Sanitizer, Lupaneta Pack 1-month, Viva-drops Lubricating Eye Drops

Drug Type: Small Molecule

Chemical Formula: C_₂H_₆O

CAS Number: 64-17-5

Unique Ingredient Identifier: 3K9958V90M

Background: A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in alcoholic beverages.

Indication: For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.

Associated Conditions: Bacterial Infections, Obstructive Hypertrophic Cardiomyopathy, Skin Irritation, Bacterial skin infections, Ethylene glycol overdose, Fat occlusion in central venous catheter, Methanol overdose

Associated Therapies: Hand Hygiene, Skin disinfection

Clinical Trials

Alcohol and Implicit Process in Sexual Risk Behavior in MSM

Phase 1

Completed

Conditions: Alcohol Drinking
Men
Sex Behavior

Interventions: Other: Placebo (non-alcoholic beverage)
Drug: Alcohol

First Posted Date: 2017-12-04

Last Posted Date: 2021-07-23

Lead Sponsor: Syracuse University

Target Recruit Count: 260

Registration Number: NCT03361384

Locations: 🇺🇸
University of South Dakota, Vermillion, South Dakota, United States
🇺🇸
Boston University, Boston, Massachusetts, United States
🇺🇸
Syracuse University, Syracuse, New York, United States

The Alcohol-Pain Connection: Mechanisms and Genetic/Psychological Correlates

Phase 1

Completed

Conditions: Pain
Alcohol Drinking
Acute Pain
Drinking Behavior

Interventions: Drug: Placebo Alcohol
Drug: Low Alcohol
Drug: Moderate Alcohol
Other: No Pain Induction
Other: Pain Induction

First Posted Date: 2017-10-17

Last Posted Date: 2022-08-17

Lead Sponsor: Syracuse University

Target Recruit Count: 379

Registration Number: NCT03311594

Locations: 🇺🇸
Syracuse University, Syracuse, New York, United States

Nicotinic Receptor Genetic Variation and Alcohol Reward

Phase 1

Recruiting

Conditions: Alcohol Drinking

Interventions: Drug: Alcohol (Oral)
Drug: Alcohol (IV)
Drug: Alcohol (Ethanol)

First Posted Date: 2017-09-27

Last Posted Date: 2025-05-04

Lead Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Target Recruit Count: 128

Registration Number: NCT03294460

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Percutaneous Ethanol Injection for Benign Cystic Thyroid Nodules

Phase 1

Completed

Conditions: Thyroid Nodule

Interventions: Drug: ethanol injection

First Posted Date: 2017-08-22

Last Posted Date: 2020-05-15

Lead Sponsor: hassan harby mohamed

Target Recruit Count: 1

Registration Number: NCT03257930

Locations: 🇪🇬
Assiut University, Assiut, Egypt

Influence of n-Acetylcysteine Maintenance on Alcohol Effects

Early Phase 1

Completed

Conditions: Alcohol Use Disorder

Interventions: Drug: Alcohol
Drug: Placebos
Drug: N-acetyl cysteine

First Posted Date: 2017-07-13

Last Posted Date: 2021-01-26

Lead Sponsor: William Stoops

Target Recruit Count: 14

Registration Number: NCT03216954

Locations: 🇺🇸
University of Kentucky, Lexington, Kentucky, United States

Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores

Phase 2

Completed

Conditions: Recurrent Herpes Labialis

Interventions: Drug: Ethanol
Drug: Merlin

First Posted Date: 2017-06-20

Last Posted Date: 2018-09-12

Lead Sponsor: Topical Remedy

Target Recruit Count: 451

Registration Number: NCT03192306

Locations: 🇺🇸
Optimal Research, Austin, Texas, United States

Neuroendocrine Response to Oral Alcohol Administration

Phase 1

Completed

Conditions: Alcohol Abuse

Interventions: Other: Alcoholic Beverage
Other: Non-Alcoholic Beverage
Drug: Ethanol

First Posted Date: 2017-05-24

Last Posted Date: 2022-08-04

Lead Sponsor: Yale University

Target Recruit Count: 64

Registration Number: NCT03165942

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Essential Oils With and Without Alcohol: Substantivity and Antiplaque Effect

Phase 4

Conditions: Dental Plaque
Oral Biofilm
Periodontitis

Interventions: Drug: Alcohol free essential oils
Drug: Essential oils
Other: Water

First Posted Date: 2017-05-09

Last Posted Date: 2017-05-09

Lead Sponsor: University of Santiago de Compostela

Target Recruit Count: 20

Registration Number: NCT03146390

Locations: 🇪🇸
University of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain

Effectiveness of Alcohol Swabs for Preventing Infections During Vaccination

Phase 3

Conditions: Skin Infection

Interventions: Drug: No alcohol
Drug: Alcohol

First Posted Date: 2017-04-27

Last Posted Date: 2017-05-02

Lead Sponsor: University of Toronto

Target Recruit Count: 170

Registration Number: NCT03131843

Locations: 🇨🇦
Pediatrician Clinic, North York, Ontario, Canada

Combined Alcohol and Cannabis Effects on Skills of Young Drivers

Early Phase 1

Completed

Conditions: Psychomotor Impairment

Interventions: Drug: delta 9 tetrahydrocannabinol
Drug: placebo delta 9 tetrahydrocannabinol
Drug: Placebo alcohol
Drug: Alcohol

First Posted Date: 2017-04-10

Last Posted Date: 2020-02-10

Lead Sponsor: Centre for Addiction and Mental Health

Target Recruit Count: 85

Registration Number: NCT03106363

Locations: 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy